Evidence map›Paper›PMID 22293551›Full record

ArticleJournal of acquired immune deficiency syndromes (1999)2012

Determination of optimized multidisciplinary care team for maximal antiretroviral therapy adherence.

Michael A Horberg, Leo B Hurley, William J Towner, Michael W Allerton, Beth T Tang, Sheryl L Catz, Michael J Silverberg, Charles P Quesenberry

Abstract read
In one paragraph

Article in Journal of acquired immune deficiency syndromes (1999), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 4 pooled it
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 4 syntheses or guidelines pooled it, 68 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. The (Contrasted) Ethics of Covid-19 and HIV: Will the Favor be Returned?Journal of healthcare, science and the humanities · 2021
    Article
  12. Clinic-Level Factors Associated With Time to Antiretroviral Initiation and Viral Suppression in a Large, Urban Cohort.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2020
    Article
  13. Article
  14. Immediate Antiretroviral Therapy Decreases Mortality Among Patients With High CD4 Counts in China: A Nationwide, Retrospective Cohort Study.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2018
    Observational
  15. Advancing the Science and Practice of Medication Adherence.Journal of general internal medicine · 2018
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Michael A HorbergMid-Atlantic Permanente Research Institute, Rockville, MD 20852, USA. michael.horberg@kp.org
Leo B Hurley
William J Towner
Michael W Allerton
Beth T Tang
Sheryl L Catz
Michael J Silverberg
Charles P Quesenberry
Kaiser Permanente · USKaiser Permanente Washington Health Research Institute · US

Funding

HIV Infection, Antiretroviral Therapy, Cancer Incidence and ProgressionK01AI071725 · NIAID · KAISER FOUNDATION RESEARCH INSTITUTE · PI SILVERBERG, MICHAEL J · 2007 to 2011
$702k
Optimizing Multidisciplinary HIV Care Team for Maximal HAART AdherenceR21MH085553 · NIMH · KAISER FOUNDATION RESEARCH INSTITUTE · PI HORBERG, MICHAEL ALAN · 2009 to 2010
$442k
NIAID NIH HHS K01 AI071725NIAID NIH HHS K01AI071725NIMH NIH HHS 1R21MH085553-01A1NIMH NIH HHS R21 MH085553
6 · The paper itself

Abstract

objectiveWe seek to determine the optimized multidisciplinary care team (MDCT) composition for antiretroviral therapy (ART) adherence.

methodsWe analyzed all new regimen starts (n = 10,801; 7071 ART naive, 3730 ART experienced) among HIV-positive patients in Kaiser Permanente California from 1996 to 2006. We measured 12-month adherence to ART (pharmacy refill methodology) and medical center-specific patient exposure to HIV/infectious disease specialist (reference group), non-HIV primary care provider, clinical pharmacist, nurse case manager, non-nurse care coordinator, dietician, social worker/benefits coordinator, health educator, and mental health worker. We used recursive partitioning to ascertain potential MDCT compositions associated with maximal mean ART adherence. We then employed mixed linear regression with clustering by provider and medical center (adjusting for ART experience, age, gender, race/ethnicity, HIV risk, hepatitis C virus coinfection, ART regimen class, and calendar year) to test which potential MDCT combination identified had statistically significant association with ART adherence.

resultsWe found maximal increase in adherence with pharmacist plus coordinator plus primary care provider combination (8.1% ART adherence difference compared with reference; 95% confidence interval: 2.7% to 13.5%). Other MDCT teams with significantly (P < 0.05) improved adherence compared with specialist only were nurse plus social worker with primary care provider (7.5%; 5.4% to 9.7%), specialist plus mental health worker (6.5%; 2.6% to 10.4%), pharmacist plus social worker plus primary care provider (5.7%; 4.1% to 7.4%), and pharmacist plus primary care provider (3.3%; 0.8% to 5.8%). Among these MDCTs, there were no significant differences in mean adherence, odds of maximal viral control, or CD4+ changes at 12 months (except pharmacist plus primary care provider).

conclusionsVarious MDCTs were associated with improved adherence, including ones that did not include the HIV specialist but included primary care plus other health professionals. These findings have application to the HIV care team design.

Indexed as

AdolescentAdultAgedAged, 80 and overAnti-HIV AgentsAntiretroviral Therapy, Highly ActiveCaliforniaCohort StudiesDelivery of Health CareFemaleHIV InfectionsHumansMaleMiddle AgedPatient ComplianceYoung AdultAnti-HIV Agents

Identifiers

PMID22293551
PMCPMC3360831
OpenAlexW2095550850

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.